You are here

Edsivo

FDA rejects Acer's rare disease drug, asks for new trial — shares crate

Endpoints

Wed, 06/26/19 - 10:11 am

Acer Therapeutics

clinical trials

Ehlers-Danlos syndrome

FDA Action Alert: Regeneron, Sanofi, Celgene

BioSpace

Mon, 06/24/19 - 07:27 pm

Acer Therapeutics

Dova Pharmaceuticals

Nabriva Therapeutics

Mark Your Calendar For These June PDUFA Dates

Yahoo/Benzinga

Sat, 06/1/19 - 12:52 pm

Amag Pharmaceuticals

Acer Therapeutics